The Pennsylvania Opioid Data Dashboard provides data behind Pennsylvania's response to the opioid crisis.

The Wolf Administration is helping to rescue opioid use disorder patients and children born suffering from withdrawal symptoms by enhancing the state's response to the opioid epidemic.

The Wolf Administration is increasing access to treatment for people suffering with opioid use disorder. This tells the story of treatment within the state of Pennsylvania.

The Wolf Administration is working to reduce over-prescribing of opioids through use of the the Prescription Drug Monitoring Program and prescribing guidelines.

This dataset contains information on the number of doses given for Naloxone throughout the Commonwealth of Pennsylvania by County. If a (-1) is listed in the county it means Not Recorded, as this field was blank by the Patient Care Report (PCR) vendor or the EMS Provider. Data is updated Quarterly starting with the first Quarter of Calendar Year 2018.

View quarterly trends in overdose rates for Any Drug Overdoses, Any Opioid Overdoses and Heroin Overdoses at the state and county level.
Please see Overdose Data Technical Notes for additional details: https://www.health.pa.gov/topics/Documents/Opioids/OverdoseDataTechnicalNotes.pdf

This dataset contains aggregate death data at the state and county level for Pennsylvania residents. The data are displayed by year, race/ethnicity, gender, age group and cause of death.

View quarterly trends in opioid dispensation data for all Schedule II-V opioids.
Please see PDMP Data Technical Notes for additional details: http://www.health.pa.gov/Your-Department-of-Health/Offices%20and%20Bureaus/PaPrescriptionDrugMonitoringProgram/Documents/PDMPDataTechnicalNotes.pdf
More information from U.S. Department of Justice
https://www.deadiversion.usdoj.gov/schedules/
Schedule I Controlled Substances
Substances in this schedule have no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse.
Some examples of substances listed in Schedule I are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), peyote, methaqualone, and 3,4-methylenedioxymethamphetamine ("Ecstasy").
Schedule II/IIN Controlled Substances (2/2N)
Substances in this schedule have a high potential for abuse which may lead to severe psychological or physical dependence.
Examples of Schedule II narcotics include: hydromorphone (Dilaudid®), methadone (Dolophine®), meperidine (Demerol®), oxycodone (OxyContin®, Percocet®), and fentanyl (Sublimaze®, Duragesic®). Other Schedule II narcotics include: morphine, opium, codeine, and hydrocodone.
Examples of Schedule IIN stimulants include: amphetamine (Dexedrine®, Adderall®), methamphetamine (Desoxyn®), and methylphenidate (Ritalin®).
Other Schedule II substances include: amobarbital, glutethimide, and pentobarbital.
Schedule III/IIIN Controlled Substances (3/3N)
Substances in this schedule have a potential for abuse less than substances in Schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence.
Examples of Schedule III narcotics include: products containing not more than 90 milligrams of codeine per dosage unit (Tylenol with Codeine®), and buprenorphine (Suboxone®).
Examples of Schedule IIIN non-narcotics include: benzphetamine (Didrex®), phendimetrazine, ketamine, and anabolic steroids such as Depo®-Testosterone.
Schedule IV Controlled Substances
Substances in this schedule have a low potential for abuse relative to substances in Schedule III.
Examples of Schedule IV substances include: alprazolam (Xanax®), carisoprodol (Soma®), clonazepam (Klonopin®), clorazepate (Tranxene®), diazepam (Valium®), lorazepam (Ativan®), midazolam (Versed®), temazepam (Restoril®), and triazolam (Halcion®).
Schedule V Controlled Substances
Substances in this schedule have a low potential for abuse relative to substances listed in Schedule IV and consist primarily of preparations containing limited quantities of certain narcotics.
Examples of Schedule V substances include: cough preparations containing not more than 200 milligrams of codeine per 100 milliliters or per 100 grams (Robitussin AC®, Phenergan with Codeine®), and ezogabine.

EDDIE is an interactive health statistics dissemination web tool where you can create customized data tables for various health related data.

The EDDIE system was developed to empower public health professionals by enhancing and expanding upon their ability to use data and statistics to drive public health policy and program decisions. Users of the EDDIE system must agree to make no attempt to identify an individual, and must agree to notify the Pennsylvania Department of Health, Division of Health Informatics immediately if an individual is inadvertently identified along with an explanation on how this occurred.

The following datasets are available:
•Air Quality
•Behavioral Risk Factor Surveillance System (BRFSS)
•Birth Defects
•Births
•Cancer Incidence
•Carbon Monoxide Poisoning Mortality
•Childhood Cancer Incidence
•Childhood Lead Poisoning
•Children Less Than Age 5 Living in Poverty
•Communicable Diseases (other than STDs)
•Deaths
•Drinking Water Quality
•Hospitalizations
•Housing by Year Built
•Infant Deaths
•Population
•Reported Pregnancies
•Reproductive Health Outcomes
•Sexually Transmitted Diseases (STDs)

EDDIE is the Pennsylvania Department of Health's primary tool for data dissemination. This is also the replacement for our legacy EpiQMS system, which has been disabled. We are working to add additional functionality to the EDDIE system in the future, including charts, county assessments, and additional maps. We are also planning to add new datasets in the coming years.

​DISCLAIMER: If you use any of the data provided, please include the following statement in any publication or release:
These data were provided by the Division of Health Informatics, Pennsylvania Department of Health. The Department specifically disclaims responsibility for any analyses, interpretations, or conclusions. Users of this data agree to make no attempt to identify an individual, and agree to notify the Division of Health Informatics, Pennsylvania Department of Health immediately if an individual is inadvertently identified along with an explanation of how this occurred.

View trends in overdose rates for Any Drug Overdoses, Any Opioid Overdoses and Heroin Overdoses at the state and county level.
Please see Overdose Data Technical Notes for additional details: http://www.health.pa.gov/Your-Department-of-Health/Offices%20and%20Bureaus/PaPrescriptionDrugMonitoringProgram/Documents/OverdoseDataTechnicalNotes.pdf